Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-29 @ 2:33 PM
Study NCT ID:
NCT04003103
Status:
COMPLETED
Last Update Posted:
2025-07-18
First Post:
2019-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-27
First Submit QC Date:
None
Study First Post Date:
2019-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-21
Results First Submit QC Date:
None
Results First Post Date:
2023-03-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL